InvestorsHub Logo
Followers 62
Posts 7557
Boards Moderated 1
Alias Born 01/02/2003

Re: None

Monday, 10/24/2022 7:33:38 PM

Monday, October 24, 2022 7:33:38 PM

Post# of 426487
Amarin's present predicament is mainly due to the invalidation of the Marine patent...If there is an opportunity to deal with this problem by marketing an improved fixed dose statin-EPA combo with Lipitor and MND-2119...every effort should be fully explored ASAP!...Reducing the requirement to take 4 EPA meds/day...plus one statin med/day(i.e. for a total of 5 CVD meds/day)...to ONE CVD med/day would help both in the areas convenience and compliance.

This is in addition to the antihypertensive and blood thinner meds that many CVD patients need to take daily.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News